Principal Street Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-133,806
Closed -$4.44M 232
2023
Q3
$4.44M Buy
133,806
+20,205
+18% +$714K 0.88% 38
2023
Q2
$4.17M Sell
113,601
-3,881
-3% -$151K 0.99% 46
2023
Q1
$4.79M Buy
117,482
+3,607
+3% +$156K 1.21% 41
2022
Q4
$5.83M Buy
113,875
+14,749
+15% +$707K 1.47% 20
2022
Q3
$4.34M Sell
99,126
-17,449
-15% -$848K 1.16% 41
2022
Q2
$6.11M Sell
116,575
-904
-0.8% -$46.1K 1.58% 12
2022
Q1
$6.08M Sell
117,479
-2,159
-2% -$112K 1.39% 21
2021
Q4
$7.06M Buy
119,638
+17,738
+17% +$879K 1.7% 10
2021
Q3
$4.38M Sell
101,900
-27,822
-21% -$1.23M 1.19% 40
2021
Q2
$5.08M Sell
129,722
-190,712
-60% -$7.42M 1.34% 21
2021
Q1
$11.6M Buy
320,434
+202,980
+173% +$7.21M 1.5% 40
2020
Q4
$4.32M Sell
117,454
-12,897
-10% -$473K 1.32% 27
2020
Q3
$4.54M Sell
130,351
-17,820
-12% -$625K 1.59% 18
2020
Q2
$4.6M Sell
148,171
-23,810
-14% -$809K 1.72% 15
2020
Q1
$5.33M Sell
171,981
-24,870
-13% -$847K 2.24% 16
2019
Q4
$7.32M Buy
196,851
+21,964
+13% +$782K 1.63% 28
2019
Q3
$5.96M Buy
174,887
+131,875
+307% +$4.8M 1.49% 36
2019
Q2
$1.77M Sell
43,012
-78,847
-65% -$3.13M 0.98% 33
2019
Q1
$4.91M Buy
+121,859
New +$4.88M 2.14% 31

Other funds holding PFE

Principal Street Partners's PFE Position: Q4 2023 in Review

Principal Street Partners sold out of Pfizer (PFE) in Q4 2023, closing a stake of 133,806 shares — an estimated $4.44M sold.

Principal Street Partners first reported a position in PFE in Q1 2019 and held it in 19 quarters. The position peaked at $11.6M in Q1 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Principal Street Partners reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Principal Street Partners sold 133,806 Pfizer shares in Q4 2023, an estimated $4.44M.
  • Principal Street Partners first reported a position in Pfizer in Q1 2019 and held it in 19 quarters.
  • Principal Street Partners's Pfizer position peaked at $11.6M in Q1 2021.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Principal Street Partners's 13F filing for Q4 2023, filed 7 Feb 2024.